| Cody Lucas Bonte, ATC | |
|
1200 W University Ave, Mitchell, SD 57301-4358 | |
| (605) 995-2600 | |
| Not Available |
| Full Name | Cody Lucas Bonte |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation - Sports Medicine |
| Location | 1200 W University Ave, Mitchell, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043732993 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081S0010X | Physical Medicine & Rehabilitation - Sports Medicine | 2000029735 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cody Lucas Bonte, ATC 212 W Elm Ave, Mitchell, SD 57301-3311 Ph: (605) 321-0264 | Cody Lucas Bonte, ATC 1200 W University Ave, Mitchell, SD 57301-4358 Ph: (605) 995-2600 |
News Archive
The Department of Health and Human Services' Agency for Healthcare Research and Quality today announced grants to support efforts by States and health systems to implement and evaluate patient safety approaches and medical liability reforms. The demonstration and planning grants are part of the patient safety and medical liability initiative that President Obama announced during a September 9, 2009 address to a joint session of Congress.
Scientists at Fred Hutchinson Cancer Research Center have discovered that microRNAs - molecular workhorses that regulate gene expression - are released by cancer cells and circulate in the blood, which gives them the potential to become a new class of biomarkers to detect cancer at its earliest stages. Muneesh Tewari, M.D., Ph.D., and colleagues describe their findings in the July 28 issue of the Proceedings of the National Academy of Sciences.
Bile duct cancer is rare and is usually detected too late. Often only extensive liver surgery can help or, in rare cases, liver transplantation. But which patients will benefit from surgery and which will not, because their risk of cancer recurrence is too high? With the oncogene MACC1 as a biomarker, physicians for the first time have a tool to decide which treatment option is best for patients with Klatskin carcinoma, one type of bile duct cancer.
Barr Pharmaceuticals, Inc. announced that its subsidiary, PLIVA - Lachema a.s., has received final approval from the U.S. Food and Drug Administration (FDA) for its generic version of Bristol-Myers Squibb Company's Taxol (paclitaxel) Injection USP, 6mg/mL, packaged in 100mg/16.7 mL and 300mg/50 mL Multiple-dose Vials.
› Verified 4 days ago
Teah Serr, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1421 S Rowley St, Mitchell, SD 57301 Phone: 605-830-2156 | |
Alexis Schaffer, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2100 N Kimball St, Mitchell, SD 57301 Phone: 605-996-8712 |